Table 4.
Subgroup | Training set | Test set | Entire set | ||||||
---|---|---|---|---|---|---|---|---|---|
High risk | Low risk | p value | High risk | Low risk | p value | High risk | Low risk | p value | |
Age (years) | 0.492 | 0.626 | 0.407 | ||||||
<50 | 68 | 75 | 73 | 71 | 141 | 146 | |||
≥50 | 191 | 184 | 198 | 175 | 389 | 359 | |||
T stage | 0.71 | 0.901 | 0.481 | ||||||
T1 | 65 | 71 | 68 | 65 | 133 | 136 | |||
T2 | 154 | 150 | 157 | 141 | 311 | 291 | |||
T3 | 30 | 32 | 34 | 32 | 64 | 64 | |||
T4 | 10 | 6 | 12 | 8 | 22 | 14 | |||
N stage | 0.547 | 0.819 | 0.547 | ||||||
N0 | 111 | 126 | 129 | 118 | 240 | 244 | |||
N1 | 95 | 90 | 84 | 82 | 179 | 172 | |||
N2 | 37 | 30 | 30 | 26 | 67 | 56 | |||
N3 | 16 | 13 | 28 | 20 | 44 | 33 | |||
M stage | 0.243 | 0.678 | 0.263 | ||||||
M0 | 251 | 255 | 264 | 241 | 515 | 496 | |||
M1 | 8 | 4 | 7 | 5 | 15 | 9 | |||
Clinical stage | 0.378 | 0.868 | 0.525 | ||||||
I | 40 | 46 | 43 | 44 | 83 | 90 | |||
II | 149 | 158 | 156 | 135 | 305 | 293 | |||
III | 62 | 51 | 65 | 62 | 127 | 113 | |||
IV | 8 | 4 | 7 | 5 | 15 | 9 | |||
Vital status | <0.001 | <0.001 | <0.001 | ||||||
Living | 195 | 242 | 224 | 230 | 419 | 472 | |||
Dead | 64 | 17 | 47 | 16 | 111 | 33 |
Chi-square test was used.